AD-1801

N/A

Report date: 2025/03/19 14:04:47

Base Information

Drug NameAD-1801
Drug Alias NameAD-1801
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Apolipoprotein E
TargetsApolipoprotein E
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEisai IncBioarctic Ab
China Registration ClassN/A

Develop Information

Active CompaniesBioarctic AbEisai Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A